首页|2019-2023年新疆巴楚县某医院肺结核患者利福平耐药状况及影响因素

2019-2023年新疆巴楚县某医院肺结核患者利福平耐药状况及影响因素

扫码查看
目的 分析巴楚县某医院肺结核患者的利福平耐药特征及相关危险因素,为当地结核病的防控治疗提供科学依据.方法 收集巴楚县人民医院2019年7月-2023年8月经病原学、分子生物学诊断确证为肺结核阳性的 1 198例患者,利用倾向性评分匹配法匹配利福平耐药(耐药组,n=92)与利福平敏感(非耐药组,n=368)的患者,回顾性队列研究方法分析患者的临床基线资料,采用logistic回归模型分析肺结核患者利福平耐药的影响因素.结果 多因素logistic回归分析显示:复治患者利福平耐药概率是初治患者的2.09(95%CI:1.28~3.42)倍,有吸烟史的患者利福平耐药概率是无吸烟史患者的3.86(95%CI:1.29~11.53)倍,合并继发性高尿酸血症患者利福平耐药概率是未合并继发性高尿酸血症患者的2.01(95%CI:1.15~3.54)倍,合并呼吸道疾病患者利福平耐药概率是未合并呼吸道疾病患者的2.32(95%CI:1.39~3.87)倍,影像学显示肺部增殖的患者利福平耐药概率是无肺部增殖患者的2.64(95%CI:1.34~5.20)倍,以上因素在耐药组和非耐药组之间差异均有统计学意义(P均<0.05).结论 肺结核患者中,复治、吸烟、合并继发性高尿酸血症、合并呼吸道疾病、肺部增殖是利福平耐药的危险因素,应对该类人群重点管控防治.
Characteristics and influencing factors of rifampicin-resistance in patients with pulmonary tuberculosis in a hospital in Bachu county,Xinjiang from 2019 to 2023
Objective To analyze the characteristics of rifampicin-resistance and related risk factors in patients with tuberculosis in a hospital in Bachu county,and provide a scientific basis for the prevention and control of local tuberculosis.Methods A total of 1 198 patients with positive etiological and molecular biological diagnosis in the People's Hospital of Bachu county from July 2019 to August 2023 were collected.The rifampin-resistant and rifampin-sensitive tuberculosis patients were matched by propensity score matching method.After the propensity score matching,92 rifampin-resistant patients and 368 non-rifampin-resistant patients were matched.The clinical baseline data of the patients were analyzed by retrospective cohort study,and the influencing factors of rifampin-resistance in patients with pulmonary tuberculosis were analyzed by logistic regression model.Results Multivariate conditional logistic regression analysis showed that the probability of rifampicin-resistance in retreated patients was 2.09(95%CI:1.28-3.42)times of that in newly diagnosed patients.The probability of rifampicin resistance in smoking patients was 3.86(95%CI:1.29-11.53)times of that in non-smoking patients.The probability of rifampicin-resistance in patients with secondary hyperuricemia was 2.01(95%CI:1.15-3.54)times of that in patients without secondary hyperuricemia.The probability of rifampicin-resistance in patients with respiratory diseases was 2.32(95%CI:1.39-3.87)times higher than that in patients without respiratory diseases.The probability of rifampicin-resistance in patients with lung imaging showing proliferation was 2.64(95%CI:1.34-5.20)times higher than that in patients without proliferation.The above factors were statistically significant between the resistant and non-resistant groups(all P<0.05).Conclusion Among the patients with pulmonary tuberculosis,retreatment,smoking,secondary hyperuricemia,respiratory diseases and pulmonary proliferation were the risk factors for rifampicin-resistance,which should be focused on control and prevention.

Pulmonary tuberculosisRifampicin-resistanceInfluencing factorsBachu county

李天心、彭凤梅、王霞、刘铠雄、魏怡凡、苏月阳、阿斯木古丽·加列勒、伊娜

展开 >

新疆医科大学基础医学院生物化学与分子生物学教研室,省部共建中亚高发病成因与防治国家重点实验室,新疆地方病分子生物学重点实验室,新疆 乌鲁木齐 830017

新疆医科大学药学院,新疆 乌鲁木齐 830017

巴楚县人民医院,新疆 喀什 843800

新疆医科大学第五临床医学院,新疆 乌鲁木齐 830017

新疆医科大学第二临床医学院,新疆 乌鲁木齐 830017

展开 >

肺结核 利福平耐药 影响因素 巴楚县

省部共建中亚高发病成因与防治国家重点实验室开放基金

SKL-HIDCA-2021-46

2024

热带医学杂志
广东省寄生虫学会 中华预防医学会

热带医学杂志

CSTPCD
影响因子:0.643
ISSN:1672-3619
年,卷(期):2024.24(5)
  • 21